The FDA's regulatory role in the ICCVAM process

ATLA Alternatives to Laboratory Animals

Volumn 32, Issue SUPPL. 1B, 2004, Pages 663-668

  Schechtman, Leonard M ^a   Stokes, William S ^b  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^b NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

Alternative methods; Drug and Cosmetic Act; Food; Food and Drug Administration (FDA); ICCVAM Authorization Act; Interagency Coordinating Committee on the Validation of Alternative Methods (ICCVAM)

Indexed keywords

ANIMAL TESTING ALTERNATIVE; ANIMAL TESTING REDUCTION; ANIMAL TESTING REFINEMENT; ANIMAL TESTING REPLACEMENT; CONFERENCE PAPER; EDUCATION PROGRAM; FOOD AND DRUG ADMINISTRATION; GOVERNMENT; LAW; PRIORITY JOURNAL; STANDARDIZATION; TOXICITY TESTING; TRAINING; VALIDATION PROCESS;

ANIMALIA;

EID: 3042616083     PISSN: 02611929     EISSN: None     Source Type: Journal    
DOI: 10.1177/026119290403201s109     Document Type: Conference Paper

References (20)

1. Sinclair, U. 1906 (1981). The Jungle. New York, NY, USA: Bantam Books.
2. FDA (Food and Drug Administration) (1906). Pure Food and Drug Act of 1906. United States Statutes at Large, 59th Congress, Session I, Chapter 3915, pp. 768-772. Available at http://coursesa.matrix.msu. edu/~hst203/documents/ pure.html.
3. FDA (Food and Drug Administration) (1906). Federal Food and Drug Act of 1906 (The "Wiley Act"), Public Law 59-384, 34 Stat. 768, (1906), 21 U.S.C. Sec 1-15 (1934). Available at http://www.fda.gov/opacom/laws/wileyact. htm.
4. FDA (Food and Drug Administration) (1981). The story of the laws behind the labels, Part I: 1906 Food and Drugs Act. FDA Consumer, June 1981. Available at http://vm.cfsan.fda.gov/~lrd/history1.html.
5. Linton, F.B. FDLI (Food and Drug Law Institute) (1950). Leaders in Food and Drug Law, Part Five. Washington, DC, USA: Food and Drug Law Institute. (Originally published in Food, Drug, and Cosmetic Law Journal 5, 771). Available at http://www. fdli.org/pubs/Journal%20Online/50th%20Anniv/ art7.pdf.
6. Linton, F.B. FDLI (Food and Drug Law Institute) (1950). Leaders in Food and Drug Law, Part Five. Washington, DC, USA: Food and Drug Law Institute. (Originally published in Food, Drug, and Cosmetic Law Journal 5, 771). Available at http://www. fdli.org/pubs/Journal%20Online/50th%20Anniv/ art7.pdf.
7. GMPI (Good Manufacturing Practice Institute). Food and Drug Legislation - The Story Behind the Law. Tampa, Florida, USA: Good Manufacturing Practice Institute/International Society for Pharmaceutical Engineering. Available at http://www.gmp1st.com/histlaw.htm.
8. FDA (Food and Drug Administration) (1981). The story of the laws behind the labels, Part II: 1938 - The Federal Food, Drug, and Cosmetic Act. FDA Consumer, June 1981. Available at http://vm.cfsan.fda.gov/~lrd/histor1a.html.
9. FDA (Food and Drug Administration) (1981). The story of the laws behind the labels, Part III: 1962 Drug Amendments. FDA Consumer, June 1981. Available at http://www.cfsan.fda.gov/~lrd/histor1b.html.
10. Bren, L. (2001). Frances Oldham Kelsey: FDA medical reviewer leaves her mark on history. FDA Consumer 35 (2): March-April 2001. Available at http://www.fda.gov/fdac/features/2001/201_kelsey.html.
11. Young, J.H. (1992). The Medical Messiahs: A Social History of Health Quackery in Twentieth-Century America. NJ, USA: Princeton University Press. Available at http://www.quackwatch.org/13Hx/MM/00.html.
12. Russell, W.M.S. & Burch, R.L. (1959). The Principles of Humane Experimental Technique, 238pp. London, UK: Methuen. Available at http://altweb.jhsph.edu/publications/humane_exp/het-toc.htm.
13. Stokes, W.S. & Hill, R. (2001). The role of the Interagency Coordinating Committee on the Validation of Alternative Methods in the evaluation of new toxicological testing methods. In Progress in the Reduction, Refinement and Replacement of Animal Experimentation (ed. M. Balls, A-M. van Zeller & M.E. Halder), pp. 385-394. Amsterdam, The Netherlands: Elsevier Science B.V.
14. ICCVAM (Interagency Coordinating Committee on the Validation of Alternative Methods) (2001). Annual Progress Report of the Interagency Coordinating Committee on the Validation of Alternative Methods. Research Triangle Park, NC, USA: NIEHS. Available at http://iccvam.niehs.nih.gov.
15. Worth, A.P. & Balls, M. (2001). The role of ECVAM in promoting the regulatory acceptance of alternative methods in the European Union. ATLA 29, 525-535.
16. ICCVAM, Interagency Coordinating Committee on the Validation of Alternative Methods (2000). ICCVAM Authorization Act of 2000, Public Law 106-545, 114 Stat. 2721 (to be codified at 42 U.S.C. Sec. 285l-2). Available at http://www.access.gpo.gov/nara/publaw/106publ.html.
17. Stokes, W.S., Schechtman, L.M. & Hill, R.N. (2002). The Interagency Coordinating Committee on the Validation of Alternative Methods (ICCVAM): a review of the test method evaluation process and current international collaborations with the European Centre for the Validation of Alternative Methods (ECVAM). ATLA 30, Suppl. 2, 23-32.
18. Schechtman, L.M. & Stokes, W.S. (2002). ECVAM-ICCVAM: prospects for future collaboration. ATLA 30, Suppl. 2, 227-236.
19. ICCVAM, Interagency Coordinating Committee on the Validation of Alternative Methods (1997). Validation and Regulatory Acceptance of Toxicological Test Methods: A Report of the Ad Hoc Interagency Coordinating Committee on the Validation of Alternative Methods. NIH Publication No. 97-3981. Research Triangle Park, NC, USA: NIEHS. Available at http://iccvam.niehs.nih. gov/docs/guidelines/validate.pdf.
20. ICCVAM, Interagency Coordinating Committee on the Validation of Alternative Methods (2003). ICCVAM Guidelines for the Nomination and Submission of New, Revised, and Alternative Test Methods. NIH Publication No. 03-4508. Research Triangle Park, NC, USA: NIEHS. Available at http://iccvam.niehs.nih. gov/docs/guidelines/subguide.htm.